Works matching IS 1758-8340 AND DT 2023

Results: 178
    1

    Phase Ib study of HSP90 inhibitor, onalespib (AT13387), in combination with paclitaxel in patients with advanced triple-negative breast cancer.

    Published in:
    Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231217976
    By:
    • Williams, Nicole O.;
    • Quiroga, Dionisia;
    • Johnson, Courtney;
    • Brufsky, Adam;
    • Chambers, Mara;
    • Bhattacharya, Saveri;
    • Patterson, Maria;
    • Sardesai, Sagar D.;
    • Stover, Daniel;
    • Lustberg, Maryam;
    • Noonan, Anne M.;
    • Cherian, Mathew;
    • Bystry, Darlene M.;
    • Hill, Kasey L.;
    • Chen, Min;
    • Phelps, Mitch A.;
    • Grever, Michael;
    • Stephens, Julie A.;
    • Ramaswamy, Bhuvaneswari;
    • Carson III, William E.
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9

    Inflammatory indices as prognostic markers in metastatic colorectal cancer patients treated with chemotherapy plus Bevacizumab.

    Published in:
    Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231212184
    By:
    • Passardi, Alessandro;
    • Azzali, Irene;
    • Bittoni, Alessandro;
    • Marisi, Giorgia;
    • Rebuzzi, Francesca;
    • Molinari, Chiara;
    • Bartolini, Giulia;
    • Matteucci, Laura;
    • Sullo, Francesco Giulio;
    • Debonis, Silvia Angela;
    • Gallio, Chiara;
    • Monti, Manlio;
    • Valgiusti, Martina;
    • Muratore, Margherita;
    • Rapposelli, Ilario Giovanni;
    • Ulivi, Paola;
    • Frassineti, Giovanni Luca
    Publication type:
    Article
    10

    Peripheral blood lymphocytes predict clinical outcomes in hormone receptor-positive HER2-negative advanced breast cancer patients treated with CDK4/6 inhibitors.

    Published in:
    Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231204857
    By:
    • Zattarin, Emma;
    • Mariani, Luigi;
    • Menichetti, Alice;
    • Leporati, Rita;
    • Provenzano, Leonardo;
    • Ligorio, Francesca;
    • Fucà, Giovanni;
    • Lobefaro, Riccardo;
    • Lalli, Luca;
    • Vingiani, Andrea;
    • Nichetti, Federico;
    • Griguolo, Gaia;
    • Sirico, Marianna;
    • Bernocchi, Ottavia;
    • Marra, Antonio;
    • Corti, Chiara;
    • Zagami, Paola;
    • Agostinetto, Elisa;
    • Jacobs, Flavia;
    • Di Mauro, Pierluigi
    Publication type:
    Article
    11
    12
    13
    14

    Clinical practice in prostate PET imaging.

    Published in:
    Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231213618
    By:
    • Huls, Sean J.;
    • Burkett, Brian;
    • Ehman, Eric;
    • Lowe, Val J.;
    • Subramaniam, Rathan M.;
    • Kendi, A. Tuba
    Publication type:
    Article
    15

    Real-world treatment patterns and clinical outcomes in patients with stage III non-small cell lung cancer: results of KINDLE-Egypt cohort.

    Published in:
    Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231212182
    By:
    • Aboelhassan, Rasha;
    • Sobeih, Mohamed Emam;
    • El-Din, Mohamed Alm;
    • Ghali, Ramy R.;
    • El-Din, Ibtessam Saad;
    • Khorshid, Ola;
    • Mokhtar, Mohsen;
    • Rabea, Ahmed Magdy;
    • Belal, Abdelaziz;
    • Azim, Hamdy A.;
    • Abdullah, Mohamed;
    • Elnahas, Tamer;
    • Tawfik, Hesham;
    • Abdelwahab, Sherif;
    • Elsaid, Amr Abdelaziz;
    • Hashem, Tarek;
    • Mancy, Mohamed;
    • Farag, Heba
    Publication type:
    Article
    16

    The microtubule inhibitor eribulin demonstrates efficacy in platinum-resistant and refractory high-grade serous ovarian cancer patient-derived xenograft models.

    Published in:
    Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231208674
    By:
    • Ho, Gwo Yaw;
    • Vandenberg, Cassandra J.;
    • Lim, Ratana;
    • Christie, Elizabeth L.;
    • Garsed, Dale W.;
    • Lieschke, Elizabeth;
    • Nesic, Ksenija;
    • Kondrashova, Olga;
    • Ratnayake, Gayanie;
    • Radke, Marc;
    • Penington, Jocelyn S.;
    • Carmagnac, Amandine;
    • Heong, Valerie;
    • Kyran, Elizabeth L.;
    • Zhang, Fan;
    • Traficante, Nadia;
    • Huang, Ruby;
    • Dobrovic, Alexander;
    • Swisher, Elizabeth M.;
    • McNally, Orla
    Publication type:
    Article
    17
    18

    CF33-hNIS-anti-PD-L1 oncolytic virus followed by trastuzumab-deruxtecan in a patient with metastatic triple negative breast cancer: a case study.

    Published in:
    Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231210675
    By:
    • Yuan, Yuan;
    • Egelston, Colt;
    • Colunga Flores, Oscar;
    • Chaurasiya, Shyambabu;
    • Lin, David;
    • Chang, Helen;
    • Chong, Leslie Mi Ok;
    • Seiz, Amanda;
    • Shah, Monil;
    • Meisen, W. Hans;
    • Tang, Aileen;
    • Martinez, Norma;
    • Pickett, Wichanee;
    • Murga, Mireya;
    • Yost, Susan E.;
    • Stewart, Daphne;
    • Zhang, Jianying;
    • Ede, Nicholas;
    • Modi, Badri;
    • Kessler, Jonathan
    Publication type:
    Article
    19
    20
    21
    22

    Tumor response assessment by measuring the single largest lesion per organ in advanced non-small cell lung cancer patients treated with PD-1/PD-L1 inhibitor.

    Published in:
    Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231200463
    By:
    • He, Li-Na;
    • Chen, Tao;
    • Fu, Sha;
    • Jiang, Yongluo;
    • Zhang, Xuanye;
    • Chen, Chen;
    • Du, Wei;
    • Luo, Linfeng;
    • Li, Anlin;
    • Wang, Yixing;
    • Yu, Hui;
    • Zhou, Yixin;
    • Wang, Yuhong;
    • Yang, Yunpeng;
    • Huang, Yan;
    • Zhao, Hongyun;
    • Fang, Wenfeng;
    • Zhang, Li;
    • Hong, Shaodong
    Publication type:
    Article
    23
    24
    25
    26
    27
    28

    Mitochondrially targeted tamoxifen as anticancer therapy: case series of patients with renal cell carcinoma treated in a phase I/Ib clinical trial.

    Published in:
    Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231197957
    By:
    • Bielcikova, Zuzana;
    • Werner, Lukas;
    • Stursa, Jan;
    • Cerny, Vladimir;
    • Krizova, Ludmila;
    • Spacek, Jan;
    • Hlousek, Stanislav;
    • Vocka, Michal;
    • Bartosova, Olga;
    • Pesta, Michal;
    • Kolostova, Katarina;
    • Klezl, Petr;
    • Bobek, Vladimir;
    • Truksa, Jaroslav;
    • Stemberkova-Hubackova, Sona;
    • Petruzelka, Lubos;
    • Michalek, Pavel;
    • Neuzil, Jiri
    Publication type:
    Article
    29
    30
    31
    32

    Safety and effectiveness of sacituzumab govitecan in patients with metastatic triple-negative breast cancer in real-world settings: first observations from an interdisciplinary breast cancer centre in Germany.

    Published in:
    Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231200454
    By:
    • Reinisch, Mattea;
    • Bruzas, Simona;
    • Spoenlein, Jennifer;
    • Shenoy, Satyendra;
    • Traut, Alexander;
    • Harrach, Hakima;
    • Chiari, Ouafaa;
    • Cremer, Efsthatia;
    • Ataseven, Beyhan;
    • Gubelt, Lars;
    • Kuemmel, Sherko
    Publication type:
    Article
    33
    34

    External validation of the first prognostic nomogram for older adults with cancer.

    Published in:
    Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231198433
    By:
    • Tay, Yu Ling;
    • Ong, Whee Sze;
    • Liew, Sherilyn Zi Hui;
    • Chowdhury, Anupama Roy;
    • Chan, Johan;
    • Ramalingam, Mothi Babu;
    • Rajasekaran, Tanujaa;
    • Tan, Tira J.;
    • Krishna, Lalit;
    • Lai, Olive;
    • Chow, Agnes Lai Yin;
    • Chen, Simon;
    • Kanesvaran, Ravindran
    Publication type:
    Article
    35
    36
    37
    38

    Low neutrophil-to-lymphocyte ratio and pan-immune-inflammation-value predict nodal pathologic complete response in 1274 breast cancer patients treated with neoadjuvant chemotherapy: a multicenter analysis.

    Published in:
    Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231193732
    By:
    • Gasparri, Maria Luisa;
    • Albasini, Sara;
    • Truffi, Marta;
    • Favilla, Karin;
    • Tagliaferri, Barbara;
    • Piccotti, Francesca;
    • Bossi, Daniela;
    • Armatura, Giulia;
    • Calcinotto, Arianna;
    • Chiappa, Corrado;
    • Combi, Francesca;
    • Curcio, Annalisa;
    • Della Valle, Angelica;
    • Ferrari, Guglielmo;
    • Folli, Secondo;
    • Ghilli, Matteo;
    • Listorti, Chiara;
    • Mancini, Stefano;
    • Marinello, Peter;
    • Mele, Simone
    Publication type:
    Article
    39
    40
    41

    Adverse events induced by durvalumab and tremelimumab combination regimens: a systematic review and meta-analysis.

    Published in:
    Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231198453
    By:
    • Matsumoto, Hiromi;
    • Somekawa, Kohei;
    • Horita, Nobuyuki;
    • Ueda, Suguru;
    • Kaneko, Megumi;
    • Kaneko, Ayami;
    • Fukuda, Nobuhiko;
    • Izawa, Ami;
    • Kamimaki, Chisato;
    • Tanaka, Katsushi;
    • Murohashi, Kota;
    • Fuji, Hiroaki;
    • Tagami, Yoichi;
    • Aoki, Ayako;
    • Watanabe, Keisuke;
    • Hara, Yu;
    • Kobayashi, Nobuaki;
    • Kaneko, Takeshi
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48

    Exceptional response to cetuximab monotherapy after failure of immunotherapy with a checkpoint inhibitor in a patient with metastatic head and neck squamous cell cancer: case report and review of the literature.

    Published in:
    Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231193722
    By:
    • Bloomer, Chance H.;
    • Gavrila, Elena;
    • Burcher, Kimberly M.;
    • Kalada, John M.;
    • Chang, Mark J.;
    • Gebeyehu, Rediet R.;
    • Asare, Elsabeth;
    • Khoury, Lara M.;
    • Kinney, Rebecca;
    • Frizzell, Bart;
    • Sullivan, Christopher A.;
    • Bunch, Paul M.;
    • Porosnicu, Mercedes
    Publication type:
    Article
    49
    50